Study of a drug to reduce aggression in Fragile X syndrome
Part of Brain & nervous system, Genetic & congenital clinical trials.
This trial tests an investigational drug to reduce aggressive behavior in men with Fragile X syndrome. It aims to see if the drug can help control disruptive outbursts and improve daily life.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be male and between 18 and 45 years old.
- You must have a genetic test confirming Fragile X syndrome.
- You must have frequent aggressive behavior that is hard to control.
- You must have an IQ below 70.
- You must have a caregiver who can report on your behavior most days.
- Your other medications must be at stable doses for at least the past month.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests whether a medicine called ganaxolone can reduce irritability (frequent tantrums or aggression) in children with autism. The child will take the drug or a placebo (a dummy pill) for a period, and researchers will monitor behavior and brain activity.
This trial tests an investigational medicine called MRM-3379 in males with Fragile X syndrome. It looks at how the medicine affects thinking and behavior over time.
This trial tests a new medicine called CTH120 to see if it is safe and helpful for adult men with Fragile X syndrome. You may be able to join if you meet certain health and age requirements.
This trial tests if cannabidiol (CBD) can help with anxiety and improve brain function in people with Fragile X syndrome. Participants will receive CBD or a placebo, and may have brain scans (MRI) or magnetic stimulation (TMS) to see how it works.
This trial studies whether a daily dose of CBD (a non-psychoactive compound from cannabis) affects brain activity in people with Fragile X syndrome, a genetic condition that causes intellectual disability and behavioral challenges. It aims to see if CBD can improve brain function and behavior.
This study tests an investigational drug called Codabakalner to see if it helps improve symptoms of Fragile X syndrome or autism spectrum disorder in males. It aims to find out if the drug is safe and effective.
Hear when a new Aggressive Behavior in Fragile X Syndome trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.